Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | September 16, 2016 |
| Target | Apex Laboratories Pty |
| Sector | Life Science |
| Buyer(s) | Dechra Pharmaceuticals |
| Deal Type | Add-on Acquisition |
| Deal Value | 55M AUD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Life Science |
| Revenue | 682M GBP (2022) |
Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. Dechra Pharmaceuticals was founded in 1997 and is based in Northwich, United Kingdom.
| Deal Context for Buyer | # |
|---|---|
| Overall | 12 of 16 |
| Sector: Life Science | 11 of 14 |
| Type: Add-on Acquisition | 10 of 14 |
| Country: Australia | 1 of 1 |
| Year: 2016 | 3 of 3 |
| Size (of disclosed) | 6 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-15 |
Putney
Portland, Maine, United States Putney, Inc. is a pharmaceutical company, providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. |
Buy | $200M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-01-25 |
AST Farma B.V.
Oudewater, Netherlands AST Farma B.V. is one of the major companion animal pharmaceutical companies in the Netherlands, focused on generic and generic plus products. The business and its reputation have grown strongly through launching generic plus, generic and niche novel products, and by offering added value services to veterinarians. |
Buy | - |
